HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement AER Monitoring System Funding Request Lowered For FY 2002

This article was originally published in The Tan Sheet

Executive Summary

Upgrades to FDA's dietary supplement adverse event monitoring system would be financed with $1 mil. in funding under the Bush Administration's fiscal year 2002 budget proposal.

You may also be interested in...



FDA’s Supplement AER System Nets $1.5 Mil. Under Ag Approps

FDA's dietary supplement adverse event monitoring system will receive $1.5 mil. in funding for FY 2002 under the 1agriculture appropriations conference report adopted by both the House and Senate

Dietary Supplement AER Funds Could Get Boost From Democratic Senate

FDA's dietary supplement adverse event monitoring system could receive increased funding in FY 2002 as a result of the power shift caused by the defection of Sen. James Jeffords (I-Vt.) from the Republican party May 24.

FDA Generic Drug Educational Campaign On Equivalence Being Developed

FDA's Office of Training & Communications is developing an informational campaign on the use of generic drugs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel